Key Points HIV Infections and AIDS HIV Surveillance: Completeness of the DO: continued improvement in the overall completeness of the DO in 2023: 77% Participation in LaboVIH:...

Key Points HIV Infections and AIDS HIV Surveillance: Satisfactory participation of laboratories in Bourgogne-Franche-Comté (BFC) in the HIV serology reporting survey (LaboVIH) Regional...

Key Points HIV Infections and AIDS HIV Surveillance: Coverage of Diagnostic Testing and Participation in LaboVIH on the Rise HIV testing: Testing activity is increasing and positivity...

Key Points HIV Infections and AIDS HIV Surveillance: Participation in LaboVIH: comprehensive Since 2020, laboratory participation in the LaboVIH survey has remained...

Key Points HIV Infections and AIDS HIV Surveillance Participation in LaboVIH: Comprehensive In 2023, laboratory participation in the LaboVIH survey remains comprehensive, as it was in...

Key Points HIV Infections and AIDS HIV Surveillance The two laboratories in Mayotte, one public (CHM) and the other private (Biogroup), participate in the LaboVIH survey, which...

Key Points HIV Infections and AIDS Significant increase in the HIV testing rate, particularly among those aged 50 and older, with a major contribution from the VIHTest...

Key Points HIV Infections and AIDS HIV Surveillance Participation in LaboVIH continues to rise, reaching 95% Coverage of diagnostic testing in the Grand Est region, at 72%, has...

Key Points HIV Infections and AIDS HIV Surveillance HIV lab participation is 100%: in Réunion, all laboratories participated Overall coverage of the DO is estimated at 92% in 2023 and...

Key Points HIV Infections and AIDS Participation in HIV SurveysIn 2023, fewer laboratories participated in the LaboVIH survey (80% vs. 97% in 2022). However, mandatory reporting of HIV...